Whole Shine Medical Technology Balance Sheet Health
Financial Health criteria checks 4/6
Whole Shine Medical Technology has a total shareholder equity of CN¥606.0M and total debt of CN¥367.1M, which brings its debt-to-equity ratio to 60.6%. Its total assets and total liabilities are CN¥1.7B and CN¥1.1B respectively.
Key information
60.6%
Debt to equity ratio
CN¥367.07m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥159.28m |
| Equity | CN¥605.99m |
| Total liabilities | CN¥1.09b |
| Total assets | CN¥1.69b |
Financial Position Analysis
Short Term Liabilities: 002622's short term assets (CN¥339.4M) do not cover its short term liabilities (CN¥946.7M).
Long Term Liabilities: 002622's short term assets (CN¥339.4M) exceed its long term liabilities (CN¥140.1M).
Debt to Equity History and Analysis
Debt Level: 002622's net debt to equity ratio (34.3%) is considered satisfactory.
Reducing Debt: 002622's debt to equity ratio has increased from 31.8% to 60.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 002622 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 002622 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 49% per year.